Phreesia, Inc. (NYSE:PHR) COO Sells $105,781.14 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 3,519 shares of Phreesia stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $30.06, for a total transaction of $105,781.14. Following the sale, the chief operating officer now directly owns 741,197 shares of the company’s stock, valued at $22,280,381.82. This trade represents a 0.47 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Evan Roberts also recently made the following trade(s):

• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total transaction of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Stock Performance

PHR traded down $1.20 during trading on Thursday, hitting $28.49. The stock had a trading volume of 346,852 shares, compared to its average volume of 382,462. The firm has a market cap of $1.66 billion, a PE ratio of -19.38 and a beta of 0.96. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a 50 day simple moving average of $27.14 and a 200-day simple moving average of $23.77.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the business posted ($0.58) EPS. Analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Johnson Financial Group Inc. grew its position in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after purchasing an additional 896 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Phreesia during the 4th quarter valued at about $30,000. International Assets Investment Management LLC boosted its position in shares of Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares in the last quarter. BankPlus Trust Department acquired a new stake in shares of Phreesia during the 4th quarter valued at about $34,000. Finally, Quarry LP boosted its position in shares of Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after acquiring an additional 1,923 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on PHR. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. KeyCorp raised their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Finally, Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Thirteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $31.15.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.